C-C1-04: Use of Health Plan EMR Data to Identify Chemotherapy Regimens for Advanced Lung Cancer

BACKGROUND: Several studies have demonstrated that chemotherapy prolongs survival by upwards of 3 months in patients with advanced (stage IIIb–IV) non-small cell lung cancer (NSCLC), but often at considerable costs. Analyses of SEER-Medicare data suggests that only 25% of older patients receive chem...

Full description

Saved in:
Bibliographic Details
Main Authors: Ritzwoller, Debra, Carroll, Nikki, Delate, Thomas, Freml, Jared, Hornbrook, Mark, Kushi, Lawrence, Loggers, Elizabeth
Format: Artigo
Language:Inglês
Published: Marshfield Clinic 2011
Subjects:
SELECTED ABSTRACTS - HMORN 2011: Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251388/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2011.1020.c-c1-04
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items